IP Library Granted Patent US 6,852,100
Granted Patent B1
US 6,852,100 · App. 09/348,954 · Granted Feb 8, 2005

Pouches for collecting matter excreted by the body

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,852,100
App. No.
09/348,954
Granted
Feb 8, 2005
Kind
B1
Abstract

The present invention provides a carrier which comprises a malodour counteractant (MCA), for use in an ostomy or incontinence pouch, wherein said carrier is attached directly or indirectly to the wall of the pouch. The MCA may be in the form of a coating or a matrix on the carrier, or may be attached directly to the carrier by way of an adhesive. The invention also provides a method for use in the production of an ostomy or incontinence pouch comprising attaching directly or indirectly to plastics material forming, or for forming, a pouch wall, a carrier carrying an MCA. A preferred MCA is a hydrogen peroxide generator, for example, sodium perborate, which may be used in the above carrier, or in other delivery mechanisms.

Claims (36)

1. An ostomy pouch for collecting waste excreted from a human body through a stoma, the pouch including an envelope formed of a plastic material defining a waste collection chamber, said envelope having an interior surface portion, the envelope having an opening for encircling a stoma, the envelope fitting to the human body around the stoma, the envelope having a carrier including an absorbent pad that carries and releases at least one malodour counteractant, said carrier being fixedly attached directly or indirectly to the interior surface portion of the envelope near the stomal opening, said carrier being encased against said interior surface portion by a liquid permeable cover, said carrier being unvented directly to the exterior of the pouch, said cover preventing direct contact of said malodour conteractant by a stoma while permitting the body waste to contact the absorbent pad, said absorbent pad being a composite of one or more of the following:

(i) separate layers of; (1) tissue paper, (2) sodium polyacrylate, glycerol, water, and (3) tissue paper;

(ii) separate layers of; (1) tissue paper, (2) viscose and super-absorbent fibres, and (3) tissue paper;

(iii) separate layers of; (1) tissue paper, (2) viscose and super-absorbent fibres; and

(iv) polyvinyl alcohol fibres and super-absorbent fibres.

2. The ostomy pouch according to claim 1 , wherein the malodour counteractant is a coating on part, or all, of a surface of the carrier.

3. The ostomy pouch according to claim 1 , wherein the malodour counteractant is adhered to the carrier by means of an adhesive.

4. The ostomy pouch according to claim 1 , wherein said carrier carries a matrix and at least one malodour counteractant.

5. The ostomy pouch according to claim 4 , wherein the matrix is a hygroscopic matrix.

6. The ostomy pouch according to claim 4 , wherein the matrix comprises glycerol and polyethylene glycol.

7. The ostomy pouch according to claim 4 , wherein the matrix comprises one or more surfactants.

8. The ostomy pouch according to claim 4 , wherein the matrix comprises one or more soaps.

9. The ostomy pouch according to claim 1 , wherein the malodour counteractant is an oxidising agent generator.

10. The ostomy pouch according to claim 1 , wherein the malodour counteractant comprises a hydrogen peroxide generator.

11. The ostomy pouch according to claim 1 , wherein the malodour counteractant comprises a chlorine dioxide generator.

12. The ostomy pouch according to claim 10 , wherein the hydrogen peroxide generator is a metal perborate.

13. The ostomy pouch according to claim 12 , wherein the metal perborate is sodium perborate.

14. The ostomy pouch according to claim 1 , wherein the malodour counteractant comprises one or more antibacterial agents and/or one or more fragrance additives.

15. The ostomy pouch according to claim 1 , wherein the carrier is heat sealed, or welded to the interior surface portion of the envelope.

16. The ostomy pouch according to claim 1 , wherein the malodour counteractant is effective in reducing the odor of excreted bodily fluid as smelled by a user of the pouch.

17. An ostomy pouch for collecting waste excreted from a human body through a stoma, the pouch including an envelope formed of a plastic material defining a waste collection chamber, said envelope having an interior surface portion, the envelope having an opening for encircling a stoma, the envelope fitting to the human body around the stoma, the envelope having a carrier including an absorbent pad that carries and releases at least one malodour counteractant, said malodour counteractant including a chlorine dioxide generator, said carrier being fixedly attached directly or indirectly to the interior surface portion of the envelope near the stomal opening, said carrier being encased against said interior surface portion by a liquid permeable cover, said carrier being unvented directly to the exterior of the pouch, said cover preventing direct contact of said malodour conteractant by a stoma while permitting the body waste to contact the absorbent pad.

18. The ostomy pouch according to claim 17 , wherein the malodour counteractant is a coating on part, or all, of a surface of the carrier.

19. The ostomy pouch according to claim 17 , wherein the malodour counteractant is adhered to the carrier by means of an adhesive.

20. The ostomy pouch according to claim 17 , wherein said carrier carries a matrix and at least one malodour counteractant.

21. The ostomy pouch according to claim 20 , wherein the matrix is a hygroscopic matrix.

22. The ostomy pouch according to claim 20 , wherein the matrix comprises glycerol and polyethylene glycol.

23. The ostomy pouch according to claim 20 , wherein the matrix comprises one or more surfactants.

24. The ostomy pouch according to claim 20 , wherein the matrix comprises one or more soaps.

25. The ostomy pouch according to claim 17 , wherein the absorbent pad is a composite comprising one or more of the following:

(i) separate layers of; (1) tissue paper, (2) sodium polyacrylate, glycerol, water, and (3) tissue paper;

(ii) separate layers of; (1) tissue paper, (2) viscose and super-absorbent fibres, and (3) tissue paper,

(iii) separate layers of; (1) tissue paper, (2) viscose and super-absorbent fibres; and

(iv) polyvinyl alcohol fibres and super-absorbent fibres.

26. The ostomy pouch according to claim 17 , wherein the malodour counteractant includes one or more antibacterial agents and/or one or more fragrance additives.

27. The ostomy pouch according to claim 17 , wherein the carrier is heat sealed, or welded to the interior surface portion of the envelope.

28. The ostomy pouch according to claim 17 , wherein the malodour counteractant is effective in reducing the odor of excreted bodily fluid as smelled by a user of the pouch.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Oct 25, 2019
From: WILMINGTON TRUST (LONDON) LIMITED
To: CONVATEC TECHNOLOGIES INC.
Reel/Frame 050831/0001 →
SECURITY AGREEMENT Recorded Nov 3, 2016
From: CONVATEC INC.; CONVATEC TECHNOLOGIES INC.; 180 MEDICAL, INC.; PRN MEDICAL SERVICES, LLC
To: WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL AGENT
Reel/Frame 040552/0227 →
RELEASE OF SECURITY INTEREST Recorded Nov 2, 2016
From: JPMORGAN CHASE BANK, N.A.
To: CONVATEC TECHNOLOGIES, INC.; CONVATEC LIMITED; UNOMEDICAL LIMITED; UNOMEDICAL A/S
Reel/Frame 040543/0357 →